
The ability to see dim light in darkness requires that second-order rod bipolar cells distinguish small changes in the ongoing release of glutamate-filled vesicles from rods. This task can be facilitated by rapid release, and previous estimates of rod release rates range up to 100 vesicles/s/ribbon. To measure rates and patterns of release, we engineered mice to express a bright fluorescent glutamate reporter (iGluSnFR3.v857.GPI) in rod photoreceptor cells. After validating expression, we measured glutamate release from rods under mesopic and photopic conditions. Under mesopic conditions produced by 900-nm two-photon excitation, light flashes decreased iGluSnFR3 fluorescence consistent with diminished release. Release measured during a chirp light stimulus showed low-pass-frequency characteristics, declining in power from 1 to 10 Hz. To identify single-vesicle events, we loaded iGluSnFR3-expressing rods with dextran-conjugated pHrodo or FM4-64. Brief increases in iGluSnFR3 fluorescence due to vesicle release were accompanied by simultaneous decreases in pHrodo or FM4-64 fluorescence. Tonic release measured from changes in iGluSnFR3 fluorescence occurred stochastically at rates of 20–40 vesicles/s/ribbon under both mesopic and photopic conditions. Capacitance measurements of release from rods voltage-clamped at −40-mV rods suggested a similar rate of 38 vesicles/s/ribbon. The ability of rods to maintain similar release rates over a wide range of background intensities ensures that properties of light adaptation that arise in rods are faithfully transmitted to downstream neurons. This mouse model provides a useful tool for deciphering mechanisms by which light information is transformed at the first synapse in the retina.
The epithelial Na channel (ENaC) mediates transport of Na+ in the kidney, the colon, the lung, and the sweat and salivary ducts. The activity of these channels is highly regulated and contributes to the maintenance of total body Na+, extracellular fluid volume, and plasma K+. Defects in the channel itself or in its regulation are implicated in hypertension and in other diseases. Despite progress in revealing many aspects of ENaC biology, many important questions remain unanswered. These include the following: What determines the remarkable ion selectivity of the channel? How is the channel directed to the apical plasma membrane? How does aldosterone regulate the channel? What is its role in producing urine with minimal Na+? And to what extent does the channel contribute to essential hypertension, cystic fibrosis, nephrotic syndrome, and liver failure? Here, I will discuss these questions and how they relate to our current understanding of the roles of ENaC in health and disease.
There is a pressing need for nonaddictive pain therapeutics. Despite the genetic validation of peripheral voltage-gated sodium (Nav) channels as targets for non-opioid pain therapy, isoform-selective inhibition of Nav1.7 and Nav1.8 has yielded limited efficacy in clinical studies, with Nav1.8 blockade providing statistically significant but only partial pain relief. This raises the question: if block of Nav1.8 relieves pain only partially, what is needed for better pain relief? In this study, we utilized dynamic clamp, which permits precisely calibrated functional addition or subtraction of the current from any given channel, to systematically interrogate the combinatorial landscape of multiplex abrogation of currents from Nav1.7 and Nav1.8, both major contributors to electrogenesis within dorsal root ganglion neurons. We demonstrate that partial, simultaneous attenuation of both conductances drives a supralinear increase in current threshold in many sensory neurons. Responses to Nav1.8 functional subtraction span a broad spectrum, whereas responses to Nav1.7 subtraction are comparatively uniform. Neurons with greater sensitivity to functional loss of Nav1.8 show greater suppression of excitability during combined Nav1.7–Nav1.8 attenuation, while weak Nav1.8 responders remain comparatively resistant. These findings identify electrogenic dependence on Nav1.8 as a major source of functional heterogeneity in sensory neurons and demonstrate that Nav1.7 acts cooperatively with Nav1.8 to shape the consequences of channel attenuation. Our results indicate that combined Nav1.7–Nav1.8 targeting should outperform isoform-selective block in suppressing firing in a subpopulation of pain-signaling neurons, while not producing universal suppression.
The brain requires a continuous supply of blood in proportion to its metabolic activity, a process that is disrupted in Alzheimer’s disease. However, the mechanisms responsible for altered brain blood flow regulation in Alzheimer’s disease remain poorly defined. In an earlier issue of JGP, Hariharan et al. (https://doi.org/10.1085/jgp.202614014) significantly add to our understanding of this pathology by showing that ATP-Sensitive K+ (KATP) channels in thin strand pericytes on cerebral capillaries are compromised at 6–8 weeks in the 5X-FAD mouse model of Alzheimer’s disease. They also confirmed that cerebral capillary endothelial inward rectifier K+ (KIR) channels are crippled and importantly show that this defect occurs at 2–4 months, before significant cognitive defects have been reported. Combined, these channelopathies severely attenuate electrical communication along cerebral capillaries, dampening blood flow regulation. These novel findings present new therapeutic targets to slow or possibly prevent the reduced cerebral blood flow in Alzheimer’s disease, perhaps delaying or preventing cognitive decline. Like all scientific advances, they also open the door for new areas of research.
The ER is an important regulator of Ca2+ in cells and dysregulation of ER Ca2+ homeostasis can lead to numerous pathologies. Understanding how various pharmacological and genetic perturbations of ER Ca2+ homeostasis impact cellular physiology would be facilitated by quantitative measurements of ER Ca2+ levels that allow for robust comparisons across conditions. To achieve this, we enhanced our original high dynamic range ER Ca2+ indicator, ER-GCaMP6-150, by fusing it to the HaloTag protein, which when bound to Janelia Fluor (JF) dyes creates a ratiometric ER Ca2+ probe. This probe (ER-Halo-GCaMP6-150) displayed minimal changes to the Ca2+-binding properties compared with our original ER Ca2+ probe as shown through in vitro and in cell Ca2+ calibrations. We describe a method to use this ratiometric probe for quantitative comparisons of ER Ca2+ concentrations and leverage this technique to compare ER Ca2+ levels across cell types and subcellular compartments. Using this approach, we show that the resting concentration of ER Ca2+ in primary dissociated neurons does not differ between excitatory and inhibitory subtypes nor between axonal and somatodendritic compartments. However, resting ER Ca2+ levels in neuronal somas are substantially lower than that measured in embryonic fibroblasts. The ER-Halo-GCaMP6-150 provides a robust tool to directly measure ER Ca2+ levels for studies of ER physiology across cell types and compartments.